Scalper1 News
Shares of gene-sequencing giant Illumina (ILMN) tumbled to a nearly one-year low Thursday after the stock was downgraded and a competing product arrived earlier than expected. Leerink analyst Dan Leonard downgraded Illumina to market perform from outperform and lowered his price target to 185 from 225, as he did not see any near-term catalysts for the stock. Illumina stock was down 9.5% in afternoon trading in the stock market today, near 159. “We Scalper1 News
Scalper1 News